IP Verse

Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer

EP3177645

LINDHOFER, HORST, DR.
Application Number
EP15756110A
Filing Date
Aug 10, 2015
Status
Revoked
Feb 16, 2024
Grant Date
Feb 17, 2021
External Links
Slate, Register

Biblio Summary

The patent EP3177645B1 was granted on Feb 17, 2021 by Lindhofer, Horst, Dr. The patent is currently Revoked.

Oppositions Filed by other Companies on the Patent

The table below shows 10 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ABBVIE INC.Nov 17, 2021ADMISSIBLE
DR. H. ULRICH DORRIESNov 17, 2021ADMISSIBLE
GENMAB A/SNov 17, 2021ADMISSIBLE
LAVA THERAPEUTICS N.V.Nov 17, 2021ADMISSIBLE
MORPHOSYS AGNov 17, 2021ADMISSIBLE
BOEHRINGER INGELHEIM RCV GMBH & CO KG / BOEHRINGER INGELHEIM INTERNATIONAL GMBHNov 16, 2021ADMISSIBLE
JAMES POOLE LIMITEDNov 16, 2021ADMISSIBLE
F. HOFFMANN-LA ROCHE AG / GENENTECH, INC.Nov 15, 2021ADMISSIBLE
REGENERON PHARMACEUTICALS, INC.May 26, 2021ADMISSIBLE
JANSSEN BIOTECH, INC.Mar 16, 2021WITHDRAWN

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents